Related references
Note: Only part of the references are listed.Narcan or Nar-can't: Tips and Tricks to Safely Reversing Opioid Toxicity
Kai Li et al.
ANNALS OF EMERGENCY MEDICINE (2018)
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Patil Armenian et al.
NEUROPHARMACOLOGY (2018)
Pharmacokinetic properties of intranasal and injectable formulations of naloxone for community use: a systematic review
Shawn A. Ryan et al.
PAIN MANAGEMENT (2018)
Fatal Fentanyl: One Pill Can Kill
Mark E. Sutter et al.
ACADEMIC EMERGENCY MEDICINE (2017)
Incidence of Naloxone Redosing in the Age of the New Opioid Epidemic
Ronald Klebacher et al.
PREHOSPITAL EMERGENCY CARE (2017)
Multiple Naloxone Administrations Among Emergency Medical Service Providers is Increasing
Mark Faul et al.
PREHOSPITAL EMERGENCY CARE (2017)
Characteristics of Fentanyl Overdose — Massachusetts, 2014–2016
Nicholas J. Somerville et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose
Philip Krieter et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Comparative Usability Study of a Novel Auto-Injector and an Intranasal System for Naloxone Delivery
Evan T. Edwards et al.
PAIN AND THERAPY (2015)
A response to the opioid overdose epidemic: naloxone nasal spray
Daniel P. Wermeling
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2013)
Intranasal delivery: Physicochemical and therapeutic aspects
Henry R. Costantino et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Share Paper
